Purifloh Ltd (po3) Logo

Purifloh Ltd (PO3)

___:___ · Utilities
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

PO3 Chart

Snapshot

PO3's Principal Activity is the developing its Free Radical Generator ("FRG") technology for a range of applications across three opportunities: Indoor air purification, Water sanitation and Medical sterilisation.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -118.69%
vs ASX 200 (1yr) -78.51%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,059 of 2,413
Sector Rank 25 of 28

Key Fundamentals

Shares Issued
Sector Utilities
Similar Companies LPE / TML / RNE
EPS -$0.02
DPS $0.00
Book Value Per Share -$0.03

Broker Consensus

PO3 is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

PuriflOH Limited (PO3) in conjunction with the Somnio Group, is developing its Free Radical Generator (FRG) technology for a range of applications across three opportunities: Indoor air purification, Water sanitation and Medical sterilization.

Incorporation Details

Incorporated The Company was incorporated on 15 March 2007 in Australia and is registered in Western Australia under the name Water Resources Group Limited.

Corporate Details

Head Office South Melbourne VIC 3205
Website www.purifloh.com
Registry Link Market Services
Auditor PKF BRISBANE AUDIT
Date Listed 30 Dec 2010

Upcoming Calendar (Forecasted)

Date Event
30/08/2022 Report (Prelim)
28/10/2022 Report (Annual)
31/10/2022 Report (Annual)
28/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Dr Alex Sava Non-Executive Director Apr 2021

Dr Alex Sava

Non-Executive Director

Mr Sava is inventor of the aerosol hydrogen peroxide disinfection process (nanonebulant), that became a core technology of ASX200 company, Nanosonics Limited (NAN.ASX), Dr Sava also has experience commercialising his inventions in numerous international markets. This has provided Dr Sava with regulatory and commercial experience which will be of specific relevance to the Company as it embarks on commercial execution. Dr Sava has achieved commercial execution with the following inventions - Aerosol hydrogen peroxide disinfection process (nanonebulant); Fast and economical assay of biological and chemical contaminants in hospitals, hotels and residential premises; World-first pathogen-disinfecting technologies based on symbiotic mixtures of natural enzymes with biocides. Achieving manyfold reduction in concentration of toxic biocides without compromising biocidal efficacies - one of the friendliest to the environment disinfection processes available to hospitals worldwide.

Mr Jonathon (Jon) Evans Non-Executive Director Oct 2020

Mr Jonathon (Jon) Evans

Non-Executive Director

Mr Evans brings a range of experience in healthcare, medical research and the innovation and commercialisation of IP and related technology solutions across the Australian and broader Asia Pacific Region. His career spans over 30 years, including as CEO of an Australian Hospital Group; Director of a State-based Infectious Disease Reference Laboratory; CEO of Tellimed Health Services; Director of Health Strategy and Innovation for Victorian Government; Managing Partner of Fitzroy Health Asia Pacific and most recently as Managing Director, APAC Health Solutions Group. Mr Evans is also chairman of CEMTAS Australia.

Mr Carl Le Souef Non-Executive Director,Interim Chairman Nov 2019

Mr Carl Le Souef

Non-Executive Director,Interim Chairman

Mr Le Souef is a founding partner and co-owner of Somnio Global. He oversaw the restructuring of PuriflOH (previously known as Water Resources Group Limited) during 2013/2014, which resulted in Dilato Holdings Pty Limited emerge as the major shareholder of PuriflOH, a position it still retains. Dilato Holdings is Mr Le Souef's private investment company. Mr Le Souef was previously the sole owner and CEO of one of Australia's largest privately owned FMCG organisations, Private Formula International, a global operation that included Australia's number one selling skincare range at the time, Dr LeWinn's Private Formula. In 2009, he negotiated the sale of the company to a US based pharmaceutical major. Mr Le Souef maintains an executive role in Somnio Global and in the management of his family office investments.

Mr Simon Richard Lill Executive Director,Company Secretary Sep 2013

Mr Simon Richard Lill

Executive Director,Company Secretary

Mr Lill has a background of over 30 years of stockbroking, capital raising, management, business development and analysis for a range of small and start-up companies, in both the manufacturing and resources industries. He has assisted Mr Le Souef in the restructuring of the Company in 2013 and has managed the Company's Australian affairs since that time. He has similarly assisted the restructure of De Grey Mining Limited from his appointment in 2013 and is now Chairman of that Company. In the 3 years prior to the date of this report Mr Lill has been, or is, a director of the following - De Grey Mining Limited (appointed 2 October 2013, continuing), Mejority Capital Limited (appointed 18 May 2010; resigned 25 November 2019), XPD Soccer Gear Group Limited (appointed 29 March 2018, continuing)

Director Transactions

PO3 directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
20/05/20 Simon Lill Buy +2,000 $2.30 $4,600 On-market trade
15/05/20 Simon Lill Buy +2,970 $2.25 $6,682 On-market trade
22/11/19 Simon Lill Issued 32,500 $2.40 $78,000 Director remuneration
22/11/19 William (Bill) Parfet Issued 11,684 $3.72 $43,467 Director remuneration

Director Interests

The current holdings of PO3 directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Jonathon (Jon) Evans 30/06/2021 15,400 N/A N/A N/A
Carl Le Souef 30/06/2021 N/A 18,409,194 N/A N/A
Alex Sava 30/06/2021 108,950 N/A N/A N/A
Simon Lill 30/06/2021 288,720 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Oct 29, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Dilato Holdings Pty Ltd 18,409,194 58.41%
Upjohn Laboratories Llc 5,271,601 16.72%
Andra M Rush 650,000 2.06%
Riveck Nominees Pty Ltd 423,555 1.34%
Gemtara Investments Pty Ltd 305,576 0.97%
Steven Annear 285,597 0.91%
HSBC Custody Nominees (Australia) Limited 284,949 0.90%
BNP Paribas Nominees Pty Ltd 256,320 0.81%
Targo Holdings Pty Ltd 245,250 0.78%
Anthony Mark Van Der Steeg 223,726 0.71%
Hopetoun Nominees Pty Ltd 206,000 0.65%
Lampam Pty Ltd 170,000 0.54%
Malcolm Richmond 159,965 0.51%
Saul Zaidman 142,445 0.45%
Ferkel Pty Ltd 141,100 0.45%
Isamg Pty Ltd 135,850 0.43%
Credal International Ltd 113,895 0.36%
Ranchland Holdings Pty Ltd 100,000 0.32%
Alexei Sava 100,000 0.32%
Jeremy Stone 93,429 0.30%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 519 282 61 104 17 983

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Dilato Holdings Pty Ltd 29/10/2021 18,409,194 58.66
Upjohn Laboratories LLC 29/10/2021 5,271,601 16.80

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $1.51 30 June
2020 $2.90 30 June
2019 $3.35 28 June
2018 $0.435 29 June
PO3 Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.